Patient stratification based on senescence markers (including CD57, KIR, and NKG2A) effectively identifies individuals with variable disease risks and distinct prognostic outcomes; specifically, an elevated proportion of CD57+ NK cells in cancer patients consistently correlates with poor clinical prognosis [39]. Here, B3GAT1 is linked to cancer.